Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Rheumatoid Arthritis

  Free Subscription


7 Ann Rheum Dis
1 Arthritis Res Ther
1 Clin Rheumatol
1 Intern Med
1 J Clin Invest
1 PLoS One
1 Rheumatol Int

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Rheum Dis

  1. DE STEFANO L, D'Onofrio B, Sakellariou G, Manzo A, et al
    Progressive increase in time to referral and persistently severe clinical presentation over the years in autoantibody-negative patients with rheumatoid arthritis in the setting of an early arthritis clinic.
    Ann Rheum Dis. 2022 Apr 29. pii: annrheumdis-2022-222264.

  2. SAPER VE, Chen G, Guillerman RP, Khatri P, et al
    Response to: 'Successful treatment of plasma exchange for refractory systemic juvenile idiopathic arthritis complicated with macrophage activation syndrome and severe lung disease' by Sato et al.
    Ann Rheum Dis. 2022;81:e62.

  3. VAN LINT JA, van Hunsel FPAM, Tas SW, Vonkeman HE, et al
    Hypoglycaemia following JAK inhibitor treatment in patients with diabetes.
    Ann Rheum Dis. 2022;81:597-599.

  4. MAGGI J, Carrascal M, Soto L, Neira O, et al
    Isolation of HLA-DR-naturally presented peptides identifies T-cell epitopes for rheumatoid arthritis.
    Ann Rheum Dis. 2022 Apr 22. pii: annrheumdis-2021-220371.
    PubMed         Abstract available

  5. REIJM S, Brehler AS, Rantapaa-Dahlqvist S, Kawakami A, et al
    Cross-reactivity of anti-modified protein antibodies is also present in predisease and individuals without rheumatoid arthritis.
    Ann Rheum Dis. 2022 Apr 22. pii: annrheumdis-2022-222326.

  6. SAEVARSDOTTIR S, Stefansdottir L, Sulem P, Thorleifsson G, et al
    Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset.
    Ann Rheum Dis. 2022 Apr 25. pii: annrheumdis-2021-221754.
    PubMed         Abstract available

  7. VAN OUWERKERK L, Palmowski A, Nevins IS, Buttgereit F, et al
    Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2022 Apr 25. pii: annrheumdis-2022-222338.
    PubMed         Abstract available

    Arthritis Res Ther

  8. SHARMA S, Plant D, Bowes J, Macgregor A, et al
    HLA-DRB1 haplotypes predict cardiovascular mortality in inflammatory polyarthritis independent of CRP and anti-CCP status.
    Arthritis Res Ther. 2022;24:90.
    PubMed         Abstract available

    Clin Rheumatol

  9. DOGAN S, Kimyon G, Ozkan H, Kacmaz F, et al
    TNF-alpha, IL-6, IL-10 and fatty acids in rheumatoid arthritis patients receiving cDMARD and bDMARD therapy.
    Clin Rheumatol. 2022 Apr 25. pii: 10.1007/s10067-022-06180.
    PubMed         Abstract available

    Intern Med

  10. NAKAMURA H, Nagasawa Y, Kobayashi H, Tsukamoto M, et al
    Successful Treatment of SARS-CoV-2 Vaccination-related Activation of Rheumatoid Arthritis with Positive Findings for Epstein-Barr Virus.
    Intern Med. 2022 Apr 23. doi: 10.2169/internalmedicine.9433.
    PubMed         Abstract available

    J Clin Invest

  11. SAEKI N, Inoue K, Ideta-Otsuka M, Watamori K, et al
    Epigenetic regulator UHRF1 suppressively orchestrates pro-inflammatory gene expression in rheumatoid arthritis.
    J Clin Invest. 2022 Apr 26. pii: 150533. doi: 10.1172/JCI150533.
    PubMed         Abstract available

    PLoS One

  12. SHIRAISHI K, Chiba K, Watanabe K, Oki N, et al
    Analysis of bone erosions in rheumatoid arthritis using HR-pQCT: Development of a measurement algorithm and assessment of longitudinal changes.
    PLoS One. 2022;17:e0265833.
    PubMed         Abstract available

    Rheumatol Int

  13. KARABULUT Y, Gezer HH, Esen S, Esen I, et al
    Tofacitinib monotherapy and erectile dysfunction in rheumatoid arthritis: a pilot observational study.
    Rheumatol Int. 2022 Apr 25. pii: 10.1007/s00296-022-05132.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.